Concussion Clinical Trials 2023

Browse 100 Concussion Medical Studies Across 82 Cities

5 Phase 3 Trial · 160 Concussion Clinics

Reviewed by Michael Gill, B. Sc.
10 Concussion Clinical Trials Near Me
Top Hospitals for Concussion Clinical Trials
Image of University of Pittsburgh in Pennsylvania.
University of Pittsburgh
Pittsburgh
3Active Trials
4All Time Trials for Concussion
2017First Concussion Trial
Image of Edward Hines Jr. VA Hospital, Hines, IL in Illinois.
Edward Hines Jr. VA Hospital, Hines, IL
Hines
3Active Trials
4All Time Trials for Concussion
2019First Concussion Trial
Image of Mayo Clinic in Rochester in Minnesota.
Mayo Clinic in Rochester
Rochester
3Active Trials
2All Time Trials for Concussion
2019First Concussion Trial
Image of Naval Medical Center San Diego in California.
Naval Medical Center San Diego
San Diego
2Active Trials
4All Time Trials for Concussion
2013First Concussion Trial
Image of VA Puget Sound Health Care System Seattle Division, Seattle, WA in Washington.
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Seattle
2Active Trials
2All Time Trials for Concussion
2016First Concussion Trial
Top Cities for Concussion Clinical Trials
Image of Vancouver in British Columbia.
Vancouver
14Active Trials
Mount Saint Joseph's HospitalTop Active Site
Image of Calgary in Alberta.
Calgary
10Active Trials
University of CalgaryTop Active Site
Concussion Clinical Trials by Phase of TrialConcussion Clinical Trials by Age GroupMost Recent Concussion Clinical TrialsTop Treatments for Concussion Clinical Trials
Treatment Name
Active Concussion Clinical Trials
All Time Trials for Concussion
First Recorded Concussion Trial
HS-1000 recording
2
2
2015
PST-Concussion
1
1
2023
tDCS in Youth with mild traumatic brain injury
1
1
2023
Baseline
1
1
2022
active tDCS and cognitive training intervention
1
1
2021
Recently Completed Studies with FDA Approved Treatments for Concussion
Treatment
Year
Sponsor
Ghrelin (OXE-103)
2020
Michael Rippee, MD
Quetiapine Fumarate
2019
The University of Texas Health Science Center at San Antonio

What Are Concussion Clinical Trials?

In medical terms, a concussion is described as a mild traumatic brain injury (MTBI) that affects brain function. A jolt, blow or bump that causes sudden head movement can lead to a concussion. This impact will cause the brain to move around, inducing chemical changes and possibly damaging the brain cells.

Signs of a concussion include dizziness, nausea, headache, and fatigue. While these are early-onset symptoms, serious complications from concussions can go unnoticed and surface days and weeks later. This mandates the need for proper medical care and treatment after suffering a concussion.

There are approximately 1.6 to 3.8 million sports and recreational concussions in the U.S. every year. While most medical experts believe concussions aren’t fatal, according to CDC, the effects of a concussion can be grave. It is usually easy to recover from a concussion, but unknown and hence untreated concussions can cause severe injury or even death.

Concussion clinical trials evaluate new tools and methods to properly diagnose and clinically manage concussions, increasing the chances of complete recovery.

Why is Concussion Being Studied Through Clinical Trials?

Concussions need to be the center for research as many cases of concussion go unnoticed and fail to receive proper medical intervention. In rare events, concussions can cause a hematoma, a collection of blood on the brain, which can be fatal.

Repeated concussions can delay recovery and cause severe long-term complications, including cognitive impairment and problems with balance and coordination. There are several sports-related concussions in the U.S., incurring high healthcare costs. A single concussion costs $800.10, and that’s the direct healthcare expense. This is an increasing economic burden on the country.

Concussion clinical trials test tools and interventions to produce improved patient outcomes. They are crucial to minimizing the chances of serious complications resulting from a concussion, thereby reducing healthcare costs.

What Are The Types of Treatments Available for Concussions?

Different treatments may be used depending on the severity of the concussion.

  • Physical and brain rest
  • Break from sports and strenuous activity
  • Drinking plenty of water
  • Alcohol abstinence till recovery
  • Pain relief medication like acetaminophen (Doctors advise not to take blood thinners like aspirin as they may increase bleeding

What Are Some Recent Breakthrough Clinical Trials For Concussions?

There have been several landmark studies involving TBI in recent years. Some of the most recent studies on concussions are:

2023: Applying the Bradford Hill Criteria for Causation to Repetitive Head Impacts and Chronic Traumatic Encephalopathy-The study by world-leading experts establishes a causal link between Repetitive head impacts (RHI) like concussions and chronic traumatic encephalopathy (CTE). This research has helped make sports organizations more aware of taking CTE prevention actions after head impact incidents.

2017: Long-Term Cognitive and Neuropsychiatric Consequences of Repetitive Concussion and Head-Impact Exposure- The study establishes the short-term and long-term neuropsychiatric and neurocognitive effects of repeated concussions. This calls for measures for the improved safety of athletes, given the potential seriousness of concussions, which often go ignored.

Who Are Some Of The Key Opinion Leaders / Researchers / Institutions Conducting Concussion Clinical Trials Research?

Complete Concussion facilitates research about concussions to develop better treatments and interventions for patients.

Brain Injury Research Institute (BIRI) conducts medical research on neurological disorders, including mild traumatic brain injuries like concussions.

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 8th, 2021

Last Reviewed: August 20th, 2023

References1 Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x. https://pubmed.ncbi.nlm.nih.gov/115569412 Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. https://pubmed.ncbi.nlm.nih.gov/115569413 Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. doi: 10.1001/archinte.166.10.1092. https://pubmed.ncbi.nlm.nih.gov/167171714 Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006 May 22;166(10):1092-7. https://pubmed.ncbi.nlm.nih.gov/167171715 Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4. https://pubmed.ncbi.nlm.nih.gov/27487716 Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. https://pubmed.ncbi.nlm.nih.gov/27487717 Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9. doi: 10.1111/j.1532-5415.2005.53221.x. Erratum In: J Am Geriatr Soc. 2019 Sep;67(9):1991. https://pubmed.ncbi.nlm.nih.gov/158170198 Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9. Erratum in: J Am Geriatr Soc. 2019 Sep;67(9):1991. https://pubmed.ncbi.nlm.nih.gov/158170199 Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. doi: 10.1037//0022-3514.54.6.1063. https://pubmed.ncbi.nlm.nih.gov/339786510 Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70. https://pubmed.ncbi.nlm.nih.gov/3397865